Hardik Onco Care

vivem plus 1gm Inj. (vial)

vivem plus 1gm Inj. (vial)

₹ 0/-

Kyprolis is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with: Lenalidomide and dexamethasone; or. Dexamethasone; or. Daratumumab and dexamethasone.

Unique Specifications of our service Our Specifications

Our Coverage